XBIO
Xenetic BiosciencesDNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
+
Peers tracked
8
U.S. public peers
Grade Position
In line
vs peer average
XBIO vs peer average
58/100
XBIO vs. peer average (D vs. D)
Grade spread
D 4 · F 4
Graded peers loaded
Coverage
8 graded
100% of tracked
Peer overview
ALZN is the first available peer comparator.
Same sector: Pharmaceuticals, Biotechnology & Life Sciences · Cap $7.57M
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
XBIO
Xenetic Biosciences
ALZN
Alzamend Neuro
Grade
D
F
Momentum
63
18
Value
41
41
Sentiment
45
-
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Defensive
Grade position vs ALZN
XBIO / ALZN
Grade Position
In line
XBIO vs. peer average (D vs. D)
58/100
Momentum
63
XBIOValue
41
XBIOSentiment
45
-Rotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs XBIO
ALZN is the first peer returned for this comparison set.

